Indications and uses
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection
before using this product read the enclosed consumer information leaflet for complete directions and information adults and children 12 years of age and over: suppositories: insert 1 suppository into the vagina at bedtime for 3 nights in a row. Throw applicator away after use. external cream: Use cap to puncture seal. Squeeze a small amount of cream onto your fingertip. Gently apply the cream onto the itchy, irrit...
Miconazole nitrate, USP 200 mg (in each suppository)
Miconazole nitrate, USP 2% (external cream)
Vaginal antifungal
Vaginal antifungal
For vaginal use only
if you have never had a vaginal yeast infection diagnosed by a doctor
taking the prescription blood thinning medicine warfarin, because bleeding or bruising may occur
ask a health professional before use.
If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
Call 1-877-753-3935 Monday-Friday 9AM-5PM EST
Compare to the active ingredient in Monistat® 3*
COMBINATION PACK
Miconazole 3
Miconazole Nitrate Vaginal Suppositories, USP 200 mg & Miconazole Nitrate Vaginal Cream, USP Cream, USP 2%
VAGINAL ANTIGUNGAL
3 - DAY TREATMENT
Vaginal suppositories with 3 disposable applicators
plus external cream for itch relief
Cures most vaginal yeast infections
Relieves associated external
itching and irritation
3 MICONAZOLE NITRATE VAGINAL SUPPOSITORIES, USP 200 mg WITH
3 DISPOSABLE APPLICATORS PLUS 1 TUBE OF
MICONAZOLE NITRATE VAGINAL CREAM, USP 2%
NET WT OZ (g)
*This product is not affiliated with, manufactured by, or produced by the makers or owners or Monistat®3.
DISTRIBUTED BY: RITE AID,
30 HUNTER LANE, CAMP HILL, PA 17011
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0011822358248 | GTIN-13: 0011822358248 EAN-13: 0011822358248 GTIN-12: 011822358248 UPC-A: 011822358248 GTIN storage (14 digits): 00011822358248 | miconazole-3-combination-pack-delisted-1.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c6f86816-7da6-43ea-8c25-ac9758311cc5 | Product name | 1 | 20220118 |
| 252e11b6-1a9a-4283-a242-df2c129c496d | Product name | 3 | 20170717 |
| 3a55f4fb-5aec-4c88-0ff7-4d608ad4866a | Product name | 1 | 20140508 |
| 5b9a7965-36d2-8412-dcaf-f76a65411611 | Product name | 1 | 20140508 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| MICONAZOLE NITRATE | ACTIVE INGREDIENT | VW4H1CYW1K | 2 | |
| MICONAZOLE | ACTIVE MOIETY | 7NNO0D7S5M | 2 | |
| BENZOIC ACID | INACTIVE INGREDIENT | 8SKN0B0MIM | 2 | |
| BUTYLATED HYDROXYANISOLE | INACTIVE INGREDIENT | REK4960K2U | 2 | |
| HYDROGENATED PALM KERNEL OIL | INACTIVE INGREDIENT | FM8D1RE2VP | 2 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | 2 | |
| PEG-5 OLEATE | INACTIVE INGREDIENT | 0240V77G50 | 2 | |
| PEGOXOL 7 STEARATE | INACTIVE INGREDIENT | 3EW5AXE5X5 | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 11822-7310 | 11822-7310-7 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| MICONAZOLE NITRATE | VW4H1CYW1K | ACTIB |
| HYDROGENATED PALM KERNEL OIL | FM8D1RE2VP | IACT |
| MICONAZOLE NITRATE | VW4H1CYW1K | ACTIB |
| BENZOIC ACID | 8SKN0B0MIM | IACT |
| BUTYLATED HYDROXYANISOLE | REK4960K2U | IACT |
| MINERAL OIL | T5L8T28FGP | IACT |
| APRICOT KERNEL OIL PEG-6 ESTERS | DRG3KJZ1TJ | IACT |
| PEGOXOL 7 STEARATE | 3EW5AXE5X5 | IACT |
| WATER | 059QF0KO0R | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 8 | 2025-11-18 | monthly-update | 2026-06-03 17:40:18 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | CAPSULE, LIQUID FILLED / ORAL | 4 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / TOPICAL | 47.5 %w/w | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | SOLUTION / ORAL | 1600 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | LOTION / TOPICAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CONCENTRATE / ORAL | 12.5 mg/5ml | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | TABLET, COATED / ORAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / TOPICAL | 1 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM / TRANSDERMAL | 11.42 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | SOLUTION / ORAL | 5 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | GRANULE, FOR SUSPENSION / ORAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / ORAL | 15 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | LOTION / TOPICAL | 0.2 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | PASTE / DENTAL | 95 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / TOPICAL | 0.1 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SPRAY / TOPICAL | 1379 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUSPENSION / RECTAL | 0.1 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | CREAM / TOPICAL | 98 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | CREAM / TOPICAL | 2 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SUPPOSITORY / VAGINAL | 2 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | SYRUP / ORAL | 1 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | OINTMENT / OPHTHALMIC | 59.5 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, CHEWABLE / ORAL | 6 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | SOLUTION / ORAL | 100 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | OINTMENT / VAGINAL | 0.02 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | CREAM / VAGINAL | 20 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | FILM / SUBLINGUAL | 0.08 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | SUSPENSION / ORAL | 2.5 mg/5ml | ||
| PEGOXOL 7 STEARATE | PEGOXOL 7 STEARATE | 3EW5AXE5X5 | CREAM / TOPICAL | 640 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | LOTION / TOPICAL | NA | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | OINTMENT / TOPICAL | 0.01 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / TOPICAL | 6 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | GEL / TOPICAL | 0.1 %w/w | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | FILM, EXTENDED RELEASE / TRANSDERMAL | 34 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / VAGINAL | 402 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | GEL / TOPICAL | 2.5 %w/w | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | INJECTION / INTRAMUSCULAR | 5 %w/v | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | TABLET, FILM COATED / ORAL | 0.4 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | CREAM / VAGINAL | 10 mg | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | INJECTION, SOLUTION / INTRAMUSCULAR | 0.2 %w/v | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | INJECTION / INTRAVENOUS | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, FILM COATED / ORAL | NA | ||
| BENZOIC ACID | BENZOIC ACID | 8SKN0B0MIM | MOUTHWASH / BUCCAL | NA | ||
| MINERAL OIL | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| PEG-5 OLEATE | PEG-5 OLEATE | 0240V77G50 | CREAM / VAGINAL | 3 %w/w | ||
| BUTYLATED HYDROXYANISOLE | BUTYLATED HYDROXYANISOLE | REK4960K2U | CREAM / VAGINAL | 0.03 %w/w |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A074926-001 | M-ZOLE 3 COMBINATION PACK | MICONAZOLE NITRATE | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A074926-001 | M-ZOLE 3 COMBINATION PACK | 2%,200MG | CREAM, SUPPOSITORY / TOPICAL, VAGINAL | 1999-04-16 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 0b31d025-9cef-47d5-8a10-b389a8c59a54 | 0ec760e8-fb33-423b-b3be-52fc09d18fd5 | 2025-12-30 | Warnings | 0b31d025-9cef-47d5-8a10-b389a8c59a54 0ec760e8-fb33-423b-b3be-52fc09d18fd5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.